BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24206356)

  • 1. Extended-spectrum β-lactamase producing Escherichia coli in hospital wastewaters and sewage treatment plants in Queensland, Australia.
    Gündoğdu A; Jennison AV; Smith HV; Stratton H; Katouli M
    Can J Microbiol; 2013 Nov; 59(11):737-45. PubMed ID: 24206356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigation of beta-lactamase genes and clonal relationship among the extended-spectrum beta-lactamase producing nosocomial Escherichia coli isolates].
    Görgeç S; Kuzucu Ç; Otlu B; Yetkin F; Ersoy Y
    Mikrobiyol Bul; 2015 Jan; 49(1):15-25. PubMed ID: 25706727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended Spectrum Beta-Lactamase (ESBL)-producing bacteria isolated from hospital wastewaters, rivers and aquaculture sources in Nigeria.
    Adelowo OO; Caucci S; Banjo OA; Nnanna OC; Awotipe EO; Peters FB; Fagade OE; Berendonk TU
    Environ Sci Pollut Res Int; 2018 Jan; 25(3):2744-2755. PubMed ID: 29139076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and characterization of extended-spectrum beta-lactamase (ESBL)- and CMY-2-producing Escherichia coli isolates from healthy food-producing animals in Tunisia.
    Ben Sallem R; Ben Slama K; Sáenz Y; Rojo-Bezares B; Estepa V; Jouini A; Gharsa H; Klibi N; Boudabous A; Torres C
    Foodborne Pathog Dis; 2012 Dec; 9(12):1137-42. PubMed ID: 23194332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Cefotaxime-Resistant Escherichia coli Isolates from Healthy Cattle and Sheep in Northern Spain: Phenotypic and Genome-Based Characterization of Antimicrobial Susceptibility.
    Tello M; Ocejo M; Oporto B; Hurtado A
    Appl Environ Microbiol; 2020 Jul; 86(15):. PubMed ID: 32471914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae causing intra-abdominal infections from 9 tertiary hospitals in China.
    Liao K; Chen Y; Wang M; Guo P; Yang Q; Ni Y; Yu Y; Hu B; Sun Z; Huang W; Wang Y; Wu A; Feng X; Luo Y; Hu Z; Chu Y; Chen S; Cao B; Su J; Gui B; Duan Q; Zhang S; Shao H; Kong H; Xu Y
    Diagn Microbiol Infect Dis; 2017 Jan; 87(1):45-48. PubMed ID: 27773544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integron content of extended-spectrum-beta-lactamase-producing Escherichia coli strains over 12 years in a single hospital in Madrid, Spain.
    Machado E; Cantón R; Baquero F; Galán JC; Rollán A; Peixe L; Coque TM
    Antimicrob Agents Chemother; 2005 May; 49(5):1823-9. PubMed ID: 15855502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital and community wastewater as a source of multidrug-resistant ESBL-producing
    Davidova-Gerzova L; Lausova J; Sukkar I; Nesporova K; Nechutna L; Vlkova K; Chudejova K; Krutova M; Palkovicova J; Kaspar J; Dolejska M
    Front Cell Infect Microbiol; 2023; 13():1184081. PubMed ID: 37256105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved detection of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli in input and output samples of German biogas plants by a selective pre-enrichment procedure.
    Schauss T; Glaeser SP; Gütschow A; Dott W; Kämpfer P
    PLoS One; 2015; 10(3):e0119791. PubMed ID: 25799434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integron-mediated multidrug resistance in extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from fecal specimens in Egypt.
    Elsherif RH; Ismail DK; El-Kholy YS; Gohar NM; Elnagdy SM; Elkraly OA
    J Egypt Public Health Assoc; 2016 Jun; 91(2):73-9. PubMed ID: 27455084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli.
    Rodriguez-Villalobos H; Malaviolle V; Frankard J; de Mendonça R; Nonhoff C; Struelens MJ
    J Antimicrob Chemother; 2006 Apr; 57(4):771-4. PubMed ID: 16501056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and characterization of multidrug-resistant and extended-spectrum beta-lactamase-producing Escherichia coli from pediatric wards of a Malaysian hospital.
    Ho WS; Balan G; Puthucheary S; Kong BH; Lim KT; Tan LK; Koh XP; Yeo CC; Thong KL
    Microb Drug Resist; 2012 Aug; 18(4):408-16. PubMed ID: 22394084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of β-lactamase phenotypes and carriage of selected β-lactamase genes among Escherichia coli strains obtained from Kenyan patients during an 18-year period.
    Kiiru J; Kariuki S; Goddeeris BM; Butaye P
    BMC Microbiol; 2012 Jul; 12():155. PubMed ID: 22838634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of extended-spectrum beta-lactamase and class 1 integron integrase gene intl1 in Escherichia coli from Thai patients and healthy adults.
    Pongpech P; Naenna P; Taipobsakul Y; Tribuddharat C; Srifuengfung S
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):425-33. PubMed ID: 18564681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extended-spectrum beta-lactamase in Klebsiella pneumoniae and Escherichia coli isolates].
    Xiong Z; Zhu D; Zhang Y; Wang F
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1476-9. PubMed ID: 12509910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class 1 integrons contributes to antibiotic resistance among clinical isolates of Escherichia coli producing extended-spectrum beta-lactamases.
    Chen T; Feng Y; Yuan JL; Qi Y; Cao YX; Wu Y
    Indian J Med Microbiol; 2013; 31(4):385-9. PubMed ID: 24064647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of extended spectrum β-lactamase producing Escherichia coli from clinical, recreational water and wastewater samples associated in time and location.
    Jørgensen SB; Søraas AV; Arnesen LS; Leegaard TM; Sundsfjord A; Jenum PA
    PLoS One; 2017; 12(10):e0186576. PubMed ID: 29040337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissemination and characterisation of Escherichia coli producing extended-spectrum β-lactamases, AmpC β-lactamases and metallo-β-lactamases from livestock and poultry in Northeast India: A molecular surveillance approach.
    Tewari R; Mitra S; Ganaie F; Das S; Chakraborty A; Venugopal N; Shome R; Rahman H; Shome BR
    J Glob Antimicrob Resist; 2019 Jun; 17():209-215. PubMed ID: 30634056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Class 1 Integrons and Extended Spectrum Beta Lactamases among Multi-Drug Resistant Escherichia coli Isolates from North of Iran.
    Mehdipour Moghaddam MJ; Mirbagheri AA; Salehi Z; Habibzade SM
    Iran Biomed J; 2015; 19(4):233-9. PubMed ID: 26220727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.